Hypothesis test

Equivalence / Non-Inferiority Trial

An equivalence or non-inferiority trial is a clinical study design that tests whether a new intervention is clinically equivalent to, or no worse than, an established standard by a pre-specified margin. Codified in Schuirmann's 1987 Two One-Sided Tests (TOST) framework and embedded in EMA and FDA regulatory guidance, this design is the regulatory standard for generic drug approval and medical device testing.

Find Topic with PaperMindSoonVideoSoon

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Schuirmann, D.J. (1987). A Comparison of the Two One-Sided Tests Procedure and the Power Approach. Journal of Pharmacokinetics and Biopharmaceutics, 15(6), 657–680. DOI: 10.1007/BF01059454
  2. EMA (2010). Guideline on the Investigation of Bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1. European Medicines Agency. link

Related methods

Referenced by

ScholarGateEquivalence / Non-Inferiority Trial (Equivalence and Non-Inferiority Clinical Trial Design). Retrieved 2026-06-04 from https://scholargate.app/en/experimental-design/equivalence-trial